⏳ Fetching live dividend data...
Home › Calculator › AQST Dividend Calculator 2026
Aquestive Therapeutics, Inc. · NASDAQ
Price: $4.08 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in AQST → $1375652481.20M in 10 years · $114,409,781,030,814.56/month
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly; and AQST-109, an orally delivered epinephrine product candidate for the emergency treatment of allergic reactions, including anaphylaxis. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open AQST position with:
Real after-tax yield depends on where you live and how you hold AQST.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 49.02% | 46.22% | $4,902 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 41.67% | 38.87% | $4,167 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 39.22% | 36.42% | $3,922 / yr |
| 🇬🇧 UK ISA | 0% | 49.02% | 46.22% | $4,902 / yr |
| 🇬🇧 UK Taxable | 8.75% | 44.73% | 41.93% | $4,473 / yr |
| 🇨🇦 TFSA | 0% | 49.02% | 46.22% | $4,902 / yr |
| 🇨🇦 CA Taxable | 25% | 36.77% | 33.97% | $3,677 / yr |
| 🇦🇺 Super (pension) | 15% | 41.67% | 38.87% | $4,167 / yr |
| 🇦🇺 AU Taxable | 30% | 34.31% | 31.51% | $3,431 / yr |
| 🇩🇪 DE Taxable | 26.375% | 36.09% | 33.29% | $3,609 / yr |
| 🇫🇷 FR Taxable | 30% | 34.31% | 31.51% | $3,431 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
AQST pays quarterly — 4 times per year. Next ex-div: TBD.
How AQST compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for AQST sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2026-06-08 | 2,714 | — | — | ||
| A-Award | 2026-05-18 | 100,000 | — | — | ||
| A-Award | 2026-05-18 | 75,000 | $4.13 | $310.1K | ||
| Sale | 2026-05-15 | 8,257 | $4.29 | $35.4K | ||
| F-InKind | 2026-05-15 | 1,667 | $4.17 | $7.0K | ||
| F-InKind | 2026-05-07 | 135,690 | $4.23 | $574.0K | ||
| F-InKind | 2026-05-05 | 56,778 | $4.18 | $237.3K | ||
| F-InKind | 2026-05-05 | 335,922 | $4.18 | $1.40M | ||
| F-InKind | 2026-05-05 | 92,652 | $4.18 | $387.3K | ||
| F-InKind | 2026-05-05 | 72,734 | $4.18 | $304.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the AQST dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →